PYLARIFY PSMA PET Scan FDA Approved for Prostate Cancer — Cancer ABCs

PYLARIFY PSMA PET Scan FDA Approved for Prostate Cancer — Cancer ABCs

As many of you may know, the FDA approved the Gallium 68 PET Scan in December 2020, although it is currently only available in Los Angles, and San Francisco.  

We now have a second PSMA PET Scan that has been approved by the FDA.  This new PSMA scan, approved on May 26th, 2021, is called PYLARIFY (or PyL).  This Scan will be available very quickly in “Mid-Atlantic and southern regions” of the US, but not widely available for a while in other areas of the country, as the company (Progenics/ Lantheus) will need to ramp up their production abilities. We believe that this new PSMA scan will become widely obtainable throughout the US, by the end of 2021.  

 Watch this blog, or www.lantheus.com for updates.  

 Both of the approved PSMA PET Scans are approved for two types of prostate cancer patients:

• “…with suspected metastasis who are candidates for initial definitive therapy.”

• “…with suspected recurrence based on elevated serum prostate specific antigen (PSA) level.”


Reference 1   
Reference 2

 

Comments

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News